Advanced search
Publication Cover
Epigenomics Volume 2, 2010 - Issue 5
Submit an article Journal homepage
255
Views
0
CrossRef citations to date
0
Altmetric
Special Report

DNA Methylation and miRNA Expression Profiling in Childhood B-Cell Acute Lymphoblastic Leukemia

Zac Chatterton1 Developmental Epigenetics, Early Development & Disease Theme, Murdoch Children‘s Research Institute, Melbourne, Australia;2 Department of Pediatrics, University of Melbourne, Melbourne, AustraliaView further author information
,
Leah Morenos1 Developmental Epigenetics, Early Development & Disease Theme, Murdoch Children‘s Research Institute, Melbourne, Australia;2 Department of Pediatrics, University of Melbourne, Melbourne, AustraliaView further author information
,
Richard Saffery1 Developmental Epigenetics, Early Development & Disease Theme, Murdoch Children‘s Research Institute, Melbourne, Australia;2 Department of Pediatrics, University of Melbourne, Melbourne, AustraliaView further author information
,
Jeffrey M Craig1 Developmental Epigenetics, Early Development & Disease Theme, Murdoch Children‘s Research Institute, Melbourne, Australia;2 Department of Pediatrics, University of Melbourne, Melbourne, AustraliaView further author information
,
David Ashley3 Children‘s Cancer Centre, Royal Children‘s Hospital, Melbourne, AustraliaView further author information
&
Nicholas C Wong1 Developmental Epigenetics, Early Development & Disease Theme, Murdoch Children‘s Research Institute, Melbourne, Australia;2 Department of Pediatrics, University of Melbourne, Melbourne, Australia;3 Children‘s Cancer Centre, Royal Children‘s Hospital, Melbourne, AustraliaCorrespondence[email protected]
View further author information
Pages 697-708 | Published online: 09 Nov 2010

Bibliography

  • Bird A : Perceptions of epigenetics.Nature447(7143) , 396–398 (2007).
  • Clark SJ , HarrisonJ, FrommerM: CpNpG methylation in mammalian cells.Nat. Genet.10(1) , 20–27 (1995).
  • Lister R , PelizzolaM, DowenRH et al.: Human DNA methylomes at base resolution show widespread epigenomic differences.Nature462(7271) , 315–322 (2009).
  • Ramsahoye BH , BiniszkiewiczD, LykoF, ClarkV, BirdAP, JaenischR: Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a.Proc. Natl Acad. Sci. USA97(10) , 5237–5242 (2000).
  • Gehring M , HenikoffS: DNA methylation dynamics in plant genomes.Biochim. Biophys. Acta.1769(5–6) , 276–286 (2007).
  • Kriaucionis S , HeintzN: The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain.Science324(5929) , 929–930 (2009).
  • Tahiliani M , KohKP, ShenY et al.: Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1.Science324(5929) , 930–935 (2009).
  • Rakyan VK , HildmannT, NovikKL et al.: DNA methylation profiling of the human major histocompatibility complex: a pilot study for the human epigenome project.PLoS Biol.2(12) , e405 (2004).
  • Cheng X , BlumenthalRM: Coordinated chromatin control: structural and functional linkage of DNA and histone methylation.Biochemistry49(14) , 2999–3008 (2010).
  • Feinberg AP : A genetic approach to cancer epigenetics.Cold Spring Harb. Symp. Quant. Biol.70 , 335–341 (2005).
  • Gronbaek K , HotherC, JonesPA: Epigenetic changes in cancer.APMIS115(10) , 1039–1059 (2007).
  • Ushijima T , AsadaK: Aberrant DNA methylation in contrast with mutations.Cancer Sci.101(2) , 300–305 (2010).
  • Toyota M , AhujaN, Ohe-ToyotaM, HermanG, BaylinSB, IssaJP: CpG island methylator phenotype in colorectal cancer.Proc. Natl Acad. Sci. USA96(15) , 8681–8686 (1999).
  • Issa JP : CpG island methylator phenotype in cancer.Nat. Rev. Cancer4(12) , 988–993 (2004).
  • Kim JH , ShinSH, KwonHJ, ChoNY, KangGH: Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers.Virchows Arch.455(6) , 485–494 (2009).
  • Li B , LiuW, WangL et al.: CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma.Ann. Surg. Oncol.17(7) , 1917–1926 (2010).
  • Cheng Y , ZhangC, ZhaoJ et al.: Correlation of CpG island methylator phenotype with poor prognosis in hepatocellular carcinoma.Exp. Mol. Pathol.88(1) , 112–117 (2010).
  • Sato H , OkaT, ShinnouY et al.: Multi-step aberrant CpG island hyper-methylation is associated with the progression of adult T-cell leukemia/lymphoma.Am. J. Pathol.176(1) , 402–415 (2010).
  • Tanemura A , TerandoAM, SimMS et al.: CpG island methylator phenotype predicts progression of malignant melanoma.Clin. Cancer Res.15(5) , 1801–1807 (2009).
  • Onciu M : Acute lymphoblastic leukemia.Hematol. Oncol. Clin. North Am.23(4) , 655–674 (2009).
  • Heerema-Mckenney A , ArberDA: Acute myeloid leukemia.Hematol. Oncol. Clin. North Am.23(4) , 633–654 (2009).
  • Stone RM : Prognostic factors in AML in relation to (ab)normal karyotype.Best Pract. Res. Clin. Haematol.22(4) , 523–528 (2009).
  • Martinelli G , IacobucciI, PapayannidisC, SoveriniS: New targets for Ph+ leukemia therapy.Best Pract. Res. Clin. Haematol.22(3) , 445–454 (2009).
  • Krug U , GanserA, KoefflerHP: Tumor suppressor genes in normal and malignant hematopoiesis.Oncogene21(21) , 3475–3495 (2002).
  • Pui CH , RellingMV, DowningJR: Acute lymphoblastic leukemia.N. Engl. J. Med.350(15) , 1535–1548 (2004).
  • Greaves M : In utero origins of childhood leukemia.Early Hum. Dev.81(1) , 123–129 (2005).
  • Sabaawy HE , AzumaM, EmbreeLJ, TsaiHJ, StarostMF, HicksteinDD: Tel-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia.Proc. Natl Acad. Sci. USA103(41) , 15166–15171 (2006).
  • Calero Moreno TM , GustafssonG, GarwiczS et al.: Deletion of the INK4-locus (the p16INK4a, p14arf and p15ink4b genes) predicts relapse in children with all treated according to the Nordic protocols nopho-86 and nopho-92.Leukemia16(10) , 2037–2045 (2002).
  • Maloney KW , McgavranL, OdomLF, HungerSP: Acquisition of p16(ink4a) and p15(ink4b) gene abnormalities between initial diagnosis and relapse in children with acute lymphoblastic leukemia.Blood93(7) , 2380–2385 (1999).
  • Felix CA , NauMM, TakahashiT et al.: Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia.J. Clin. Invest.89(2) , 640–647 (1992).
  • Mullighan CG , GoorhaS, RadtkeI et al.: Genome-wide analysis of genetic alterations in acute lymphoblastic leukemia.Nature446(7137) , 758–764 (2007).
  • Zuo T , TyckoB, LiuTM, LinHJ, HuangTHM: Methods in DNA methylation profiling.Epigenomics1(3) , 331–345 (2009).
  • Laird PW : Principles and challenges of genome-wide DNA methylation analysis.Nat. Rev. Genet.11(3) , 191–203 (2010).
  • Herman JG , GraffJR, MyohanenS, NelkinBD, BaylinSB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.Proc. Natl Acad. Sci. USA93(18) , 9821–9826 (1996).
  • Gutierrez MI , SirajAK, BhargavaM et al.: Concurrent methylation of multiple genes in childhood ALL: Correlation with phenotype and molecular subgroup.Leukemia17(9) , 1845–1850 (2003).
  • Yang Y , TakeuchiS, HofmannWK et al.: Aberrant methylation in promoter-associated CpG islands of multiple genes in acute lymphoblastic leukemia.Leuk. Res.30(1) , 98–102 (2006).
  • Roman-Gomez J , Jimenez-VelascoA, AgirreX et al.: Promoter hypermethylation and global hypomethylation are independent epigenetic events in lymphoid leukemogenesis with opposing effects on clinical outcome.Leukemia20(8) , 1445–1448 (2006).
  • Kim M , Yim Sh, Cho NS et al.: Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood b-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study. Cancer Genet. Cytogenet.195(1) , 59–65 (2009).
  • Hesson LB , DunwellTL, CooperWN et al.: The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukemias.Mol. Cancer8 , 42 (2009).
  • Paulsson K , AnQ, MoormanAV et al.: Methylation of tumour suppressor gene promoters in the presence and absence of transcriptional silencing in high hyperdiploid acute lymphoblastic leukemia.Br. J. Haematol.144(6) , 838–847 (2009).
  • Bock C : Epigenetic biomarker development.Epigenomics1(1) , 99–110 (2009).
  • Stumpel DJ , SchneiderP, van Roon EH et al.: Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options. Blood114(27) , 5490–5498 (2009).
  • Dunwell TL , HessonLB, PavlovaT et al.: Epigenetic analysis of childhood acute lymphoblastic leukemia.Epigenetics4(3) , 185–193 (2009).
  • Taylor KH , Pena-HernandezKE, DavisJW et al.: Large-scale CpG methylation analysis identifies novel candidate genes and reveals methylation hotspots in acute lymphoblastic leukemia.Cancer Res.67(6) , 2617–2625 (2007).
  • Davidsson J , LilljebjornH, AnderssonA et al.: The DNA methylome of pediatric acute lymphoblastic leukemia.Hum. Mol. Genet.18(21) , 4054–4065 (2009).
  • Dunwell T , HessonL, RauchTA et al.: A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers.Mol. Cancer9 , 44 (2010).
  • Schafer E , IrizarryR, NegiS et al.: Promoter hypermethylation in MLL-R infant acute lymphoblastic leukemia: biology and therapeutic targeting.Blood115(23) , 4798–4809 (2010).
  • Bibikova M , FanJB: Goldengate assay for DNA methylation profiling.Methods Mol. Biol.507 , 149–163 (2009).
  • Milani L , LundmarkA, KiialainenA et al.: DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia.Blood115(6) , 1214–1225 (2010).
  • Taylor KH , KramerRS, DavisJW et al.: Ultradeep bisulfite sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing.Cancer Res.67(18) , 8511–8518 (2007).
  • Wang MX , WangHY, ZhaoX et al.: Molecular detection of B-cell neoplasms by specific DNA methylation biomarkers.Int. J. Clin. Exp. Pathol.3(3) , 265–279 (2010).
  • Deneberg S , GrovdalM, KarimiM et al.: Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia.Leukemia24(5) , 932–941 (2010).
  • Lister R , EckerJR: Finding the fifth base: genome-wide sequencing of cytosine methylation.Genome Res.19(6) , 959–966 (2009).
  • Flusberg BA , WebsterDR, LeeJH et al.: Direct detection of DNA methylation during single-molecule, real-time sequencing.Nat. Methods7(6) , 461–465 (2010).
  • Davalos V , EstellerM: miRNAs and cancer epigenetics: a macrorevolution.Curr. Opin Oncol.22(1) , 35–45 (2010).
  • Esquela-Kerscher A , SlackFJ: Oncomirs – miRNAs with a role in cancer.Nat. Rev. Cancer6(4) , 259–269 (2006).
  • Zhang H , LiY, LaiM: The miRNA network and tumor metastasis.Oncogene29(7) , 937–948 (2010).
  • Xie L , QianX, LiuB: miRNAs: Novel biomarkers for gastrointestinal carcinomas.Mol. Cell Biochem.341(1–2) , 291–299 (2010).
  • Seca H , AlmeidaGM, GuimaraesJE, VasconcelosMH: miR signatures and the role of miRs in acute myeloid leukemia.Eur. J. Cancer46(9) , 1520–1527 (2010).
  • Volinia S , GalassoM, CostineanS et al.: Reprogramming of miRNA networks in cancer and leukemia.Genome Res.20(5) , 589–599 (2010).
  • Schotte D , ChauJC, SylvesterG et al.: Identification of new miRNA genes and aberrant miRNA profiles in childhood acute lymphoblastic leukemia.Leukemia23(2) , 313–322 (2009).
  • Ju X , LiD, ShiQ, HouH, SunN, ShenB: Differential miRNA expression in childhood B-cell precursor acute lymphoblastic leukemia.Pediatr. Hematol. Oncol.26(1) , 1–10 (2009).
  • Mi S , LuJ, SunM et al.: miRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia.Proc. Natl Acad. Sci. USA104(50) , 19971–19976 (2007).
  • Fulci V , ColomboT, ChiarettiS et al.: Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of microRNA and mRNA expression profiles.Genes Chromosomes Cancer48(12) , 1069–1082 (2009).
  • Chen J , OdenikeO, RowleyJD: Leukaemogenesis: more than mutant genes.Nat. Rev. Cancer10(1) , 23–36 (2010).
  • Friedman JM , LiangG, LiuCC et al.: The putative tumor suppressor miRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2.Cancer Res.69(6) , 2623–2629 (2009).
  • Agirre X , Vilas-ZornozaA, Jimenez-VelascoA et al.: Epigenetic silencing of the tumor suppressor miRNA HSA-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia.Cancer Res.69(10) , 4443–4453 (2009).
  • Roman-Gomez J , AgirreX, Jimenez-VelascoA et al.: Epigenetic regulation of miRNAs in acute lymphoblastic leukemia.J. Clin. Oncol.27(8) , 1316–1322 (2009).
  • Mattick JS , TaftRJ, FaulknerGJ: A global view of genomic information – moving beyond the gene and the master regulator.Trends Genet.26(1) , 21–28 (2010).
  • Huang Y , PastorWA, ShenY, TahilianiM, LiuDR, RaoA: The behaviour of 5-hydroxymethylcytosine in bisulfite sequencing.PLoS ONE5(1) , e8888 (2010).
  • Milani L , LundmarkA, NordlundJ et al.: Allele-specific gene expression patterns in primary leukemic cells reveal regulation of gene expression by CpG site methylation.Genome Res.19(1) , 1–11 (2009).
  • Strathdee G , HolyoakeTL, SimA et al.: Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis.Clin. Cancer Res.13(17) , 5048–5055 (2007).
  • Vasilatou D , PapageorgiouS, PappaV, PapageorgiouE, DervenoulasJ: The role of miRNAs in normal and malignant hematopoiesis.Eur. J. Haematol.84(1) , 1–16 (2010).
  • Li X , LiuJ, ZhouR, HuangS, ChenXM: Gene silencing of miR22 in acute lymphoblastic leukemia involves histone modifications independent of promoter DNA methylation.Br. J. Haematol.148(1) , 69–79 (2010).
  • Zanette DL , RivadaviaF, MolfettaGA et al.: miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia.Braz. J. Med. Biol. Res.40(11) , 1435–1440 (2007).
  • Bandyopadhyay S , MitraR, MaulikU, ZhangMQ: Development of the human cancer miRNA network.Silence1(1) , 6 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.